Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease

Kathryn E. Dane, John P. Lindsley, Thomas Kickler, Michael B. Streiff, Alison Moliterno, Jennifer Yui, Rakhi Naik, Shruti Chaturvedi

Blood Adv (2021) 5 (14): 2813–2816.

https://doi.org/10.1182/bloodadvances.2021004843

Published: 2021

Journal Articles

Srivaths L, Minard CG, O’Brien SH, et al. The spectrum and severity of bleeding in adolescents with low von Willebrand factor–associated heavy menstrual bleeding. Blood Adv. 2020;4(13):3209-3216.

Blood Adv (2021) 5 (7): 1952.

https://doi.org/10.1182/bloodadvances.2021004671

Published: 2021

Journal Articles

Population pharmacokinetics of the von Willebrand factor–factor VIII interaction in patients with von Willebrand disease

Laura H. Bukkems, Jessica M. Heijdra, Nico C. B. de Jager, Hendrika C. A. M. Hazendonk, Karin Fijnvandraat, Karina Meijer, Jeroen C. J. Eikenboom, Britta A. P. Laros-van Gorkom, Frank W. G. Leebeek, Marjon H. Cnossen, Ron A. A. Mathôt

Blood Adv (2021) 5 (5): 1513–1522.

https://doi.org/10.1182/bloodadvances.2020003891

Published: 2021

Includes: Supplemental data

Journal Articles

Molecular coevolution of coagulation factor VIII and von Willebrand factor

Philip M. Zakas, Christopher W. Coyle, Anja Brehm, Marion Bayer, Barbara Solecka-Witulska, Caelan E. Radford, Christine Brown, Kate Nesbitt, Courtney Dwyer, Christoph Kannicht, H. Trent Spencer, Eric A. Gaucher, Christopher B. Doering, David Lillicrap

Blood Adv (2021) 5 (3): 812–822.

https://doi.org/10.1182/bloodadvances.2020002971

Published: 2021

Includes: Supplemental data

Journal Articles

von Willebrand factor variant D1472H has no effect in mice with humanized VWF-platelet interactions

Hannah K. Lohmeier, Tricia L. Slobodianuk, Sachiko Kanaji, Sandra L. Haberichter, Robert R. Montgomery, Veronica H. Flood

Blood Adv (2020) 4 (17): 4065–4068.

https://doi.org/10.1182/bloodadvances.2020002629

Published: 2020

Journal Articles

Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D′D3 and D4 domains

Monica Sacco, Stefano Lancellotti, Mattia Ferrarese, Francesco Bernardi, Mirko Pinotti, Maira Tardugno, Erica De Candia, Leonardo Di Gennaro, Maria Basso, Betti Giusti, Massimiliano Papi, Giordano Perini, Giancarlo Castaman, Raimondo De Cristofaro

Blood Adv (2020) 4 (14): 3405–3415.

https://doi.org/10.1182/bloodadvances.2020002334

Published: 2020

Includes: Supplemental data

Journal Articles

Recombinant vs plasma-derived von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease

Nicoletta Machin, Margaret V. Ragni

Blood Adv (2020) 4 (14): 3234–3238.

https://doi.org/10.1182/bloodadvances.2020002046

Published: 2020

Journal Articles

Low VWF: insights into pathogenesis, diagnosis, and clinical management

James S. O’Donnell

Blood Adv (2020) 4 (13): 3191–3199.

https://doi.org/10.1182/bloodadvances.2020002038

Published: 2020

Journal Articles

The spectrum and severity of bleeding in adolescents with low von Willebrand factor–associated heavy menstrual bleeding

Lakshmi Srivaths, Charles G. Minard, Sarah H. O’Brien, Allison P. Wheeler, Eric Mullins, Mukta Sharma, Robert Sidonio, Shilpa Jain, Ayesha Zia, Margaret V. Ragni, Roshni Kulkarni, Jennifer E. Dietrich, Peter A. Kouides

Blood Adv (2020) 4 (13): 3209–3216.

https://doi.org/10.1182/bloodadvances.2020002081

Published: 2020

Journal Articles

Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms

Ashley Cartwright, Simon J. Webster, Annika de Jong, Richard J. Dirven, Lisa D. S. Bloomer, Ahlam M. AL-Buhairan, Ulrich Budde, Christer Halldén, David Habart, Jenny Goudemand, Ian R. Peake, Jeroen C. J. Eikenboom, Anne C. Goodeve, Daniel J. Hampshire

Blood Adv (2020) 4 (13): 2979–2990.

https://doi.org/10.1182/bloodadvances.2018027813

Published: 2020

Includes: Supplemental data

Journal Articles

Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions

Magdolna Nagy, Gina Perrella, Amanda Dalby, M. Francisca Becerra, Lourdes Garcia Quintanilla, Jeremy A. Pike, Neil V. Morgan, Elizabeth E. Gardiner, Johan W. M. Heemskerk, Lorena Azócar, Juan Francisco Miquel, Diego Mezzano, Steve P. Watson

Blood Adv (2020) 4 (13): 2953–2961.

https://doi.org/10.1182/bloodadvances.2020001761

Published: 2020

Includes: Supplemental data

Journal Articles

von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome

Alice Taylor, Chiara Vendramin, Deepak Singh, Martin M. Brown, Marie Scully

Blood Adv (2020) 4 (2): 398–407.

https://doi.org/10.1182/bloodadvances.2019000979

Published: 2020

Includes: Supplemental data

Journal Articles

von Willebrand factor binding to myosin assists in coagulation

Veronica H. Flood, Tricia L. Slobodianuk, Daniel Keesler, Hannah K. Lohmeier, Scot Fahs, Liyun Zhang, Pippa Simpson, Robert R. Montgomery

Blood Adv (2020) 4 (1): 174–180.

https://doi.org/10.1182/bloodadvances.2019000533

Published: 2020

Journal Articles

von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD

Ferdows Atiq, Lisette M. Schütte, Agnes E. M. Looijen, Johan Boender, Marjon H. Cnossen, Jeroen Eikenboom, Moniek P. M. de Maat, Marieke J. H. A. Kruip, Frank W. G. Leebeek

Blood Adv (2019) 3 (24): 4147–4154.

https://doi.org/10.1182/bloodadvances.2019000863

Published: 2019

Journal Articles

New therapies for von Willebrand disease

Pier Mannuccio Mannucci

Blood Adv (2019) 3 (21): 3481–3487.

https://doi.org/10.1182/bloodadvances.2019000368

Published: 2019

Journal Articles

Role of the coagulation system in the pathogenesis of sickle cell disease

Md Nasimuzzaman, Punam Malik

Blood Adv (2019) 3 (20): 3170–3180.

https://doi.org/10.1182/bloodadvances.2019000193

Published: 2019

Journal Articles

von Willebrand factor self-association is regulated by the shear-dependent unfolding of the A2 domain

Changjie Zhang, Anju Kelkar, Sriram Neelamegham

Blood Adv (2019) 3 (7): 957–968.

https://doi.org/10.1182/bloodadvances.2018030122

Published: 2019

Includes: Multimedia, Supplemental data

Journal Articles

Humanized GPIbα–von Willebrand factor interaction in the mouse

Sachiko Kanaji, Jennifer N. Orje, Taisuke Kanaji, Yuichi Kamikubo, Yosuke Morodomi, Yunfeng Chen, Alessandro Zarpellon, Jerome Eberhardt, Stefano Forli, Scot A. Fahs, Rashmi Sood, Sandra L. Haberichter, Robert R. Montgomery, Zaverio M. Ruggeri

Blood Adv (2018) 2 (19): 2522–2532.

https://doi.org/10.1182/bloodadvances.2018023507

Published: 2018

Includes: Supplemental data

Journal Articles

The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium

Thejaswi Kalagara, Tracy Moutsis, Yi Yang, Karin I. Pappelbaum, Anne Farken, Lucia Cladder-Micus, Sabine Vidal-y-Sy, Axel John, Alexander T. Bauer, Bruno M. Moerschbacher, Stefan W. Schneider, Christian Gorzelanny

Blood Adv (2018) 2 (18): 2347–2357.

https://doi.org/10.1182/bloodadvances.2017013995

Published: 2018

Includes: Multimedia, Supplemental data

Journal Articles

Significant gynecological bleeding in women with low von Willebrand factor levels

Michelle Lavin, Sonia Aguila, Niall Dalton, Margaret Nolan, Mary Byrne, Kevin Ryan, Barry White, Niamh M. O’Connell, Jamie M. O’Sullivan, Jorge Di Paola, Paula D. James, James S. O’Donnell

Blood Adv (2018) 2 (14): 1784–1791.

https://doi.org/10.1182/bloodadvances.2018017418

Published: 2018

Includes: Supplemental data

NARROW

Continuous-infusion von Willebrand factor concentrate is effective for the management of acquired von Willebrand disease

Srivaths L, Minard CG, O’Brien SH, et al. The spectrum and severity of bleeding in adolescents with low von Willebrand factor–associated heavy menstrual bleeding. Blood Adv. 2020;4(13):3209-3216.

Population pharmacokinetics of the von Willebrand factor–factor VIII interaction in patients with von Willebrand disease

Molecular coevolution of coagulation factor VIII and von Willebrand factor

von Willebrand factor variant D1472H has no effect in mice with humanized VWF-platelet interactions

Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D′D3 and D4 domains

Recombinant vs plasma-derived von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease

Low VWF: insights into pathogenesis, diagnosis, and clinical management

The spectrum and severity of bleeding in adolescents with low von Willebrand factor–associated heavy menstrual bleeding

Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms

Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions

von Willebrand factor/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome

von Willebrand factor binding to myosin assists in coagulation

von Willebrand factor and factor VIII levels after desmopressin are associated with bleeding phenotype in type 1 VWD

New therapies for von Willebrand disease

Role of the coagulation system in the pathogenesis of sickle cell disease

von Willebrand factor self-association is regulated by the shear-dependent unfolding of the A2 domain

Humanized GPIbα–von Willebrand factor interaction in the mouse

The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium

Significant gynecological bleeding in women with low von Willebrand factor levels

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only